Last Posted: Sep 26, 2019
- First Biomarker-Based Screening Tool for PTSD
J Abbasi, JAMA, September 25, 2019 - Multi-omic biomarker identification and validation for diagnosing warzone-related post-traumatic stress disorder.
Dean Kelsey R et al. Molecular psychiatry 2019 Sep - Genomic Characterization of Posttraumatic Stress Disorder in a Large US Military Veteran Sample
MB Stein et al, BioRXIV, September 10, 2019 - Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veterans
J Gelernter et al, Nat NeuroSci, July 29, 2019 - Polygenic risk associated with post-traumatic stress disorder onset and severity.
Misganaw Burook et al. Translational psychiatry 2019 Jun (1) 165 - Efficacy of mobile application interventions for the treatment of post-traumatic stress disorder: A systematic review.
Wickersham Alice et al. Digital health 52055207619842986 - 19 Real World Patient-Reported Outcomes Following Pharmacogenomic Testing.
Rigby Nichole et al. CNS spectrums 2019 Feb 24(1) 183 - Genetic variation is associated with PTSD risk and aversive memory: Evidence from two trauma-Exposed African samples and one healthy European sample.
Wilker Sarah et al. Translational psychiatry 2018 Nov 8(1) 251 - Largest genome-wide association study for PTSD identifies genetic risk loci in European and African ancestries and implicates novel biological pathways
BioRXIV preprints, November 1, 2018 - In the race to use genetic tests to predict whether antidepressants will work, science might be getting left behind
R Robbins, StatNews, September 28, 2018
.png)
No hay comentarios:
Publicar un comentario